Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Head and Neck Neoplasms 10Squamous Cell Carcinoma of Head and Neck 4Oropharyngeal Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Recurrent Head and Neck Carcinoma 1Postoperative Complications 1Pancreatic Neoplasms 1Nerve Compression Syndromes 1Nasopharyngeal Neoplasms 1Melanoma 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Eyelid Squamous Cell Carcinoma 1Endometrial Neoplasms 1Dihydropyrimidine Dehydrogenase Deficiency 1Colorectal Neoplasms 1Carotid Stenosis 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Accessory Nerve Injuries 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Dihydropyrimidine Dehydrogenase Deficiency × Head & Neck × Clear all
NCT04541381 2026-05-07

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

University of Chicago

Phase NA Suspended
860 enrolled
BreastGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡